Are low dehydroepiandrosterone sulphate levels predictive for cardiovascular diseases? A review of prospective and retrospective studies
@article{Thijs2003AreLD, title={Are low dehydroepiandrosterone sulphate levels predictive for cardiovascular diseases? A review of prospective and retrospective studies}, author={Lutgarde Thijs and Robert H. Fagard and Françoise Forette and Tim S. Nawrot and Jan A. Staessen}, journal={Acta Cardiologica}, year={2003}, volume={58}, pages={403 - 410} }
Study objective — It has been suggested that low levels of dehydroepiandrosterone sulphate (DHEAS) are predictive for cardiovascular diseases in men.We aimed to review the available evidence from prospective cohort studies and retrospective case-control studies. Methods — We extracted summary statistics from 4 case-control studies and 8 cohort studies, and calculated the pooled relative risk associated with a 2 μmol/l increase in DHEAS. Main results — The number of subjects included in each of…
36 Citations
Low Dehydroepiandrosterone Sulfate is Associated With Increased Risk of Ischemic Stroke Among Women
- MedicineStroke
- 2013
Lower DHEAS levels were associated with a greater risk of ischemic stroke, even after adjustment for potential confounders, and these novel observations warrant confirmation in other populations.
Cardiovascular Risk Factors and Dehydroepiandrosterone Sulfate Among Latinos in the Boston Puerto Rican Health Study
- MedicineJournal of the Endocrine Society
- 2019
In this large study of Latinos with a heavy cardiovascular risk factor burden, significant associations between cardiovascular disease (CVD) risk factors and DHEAS are observed, with variations by sex, which improves understanding of the role D HEAS may play in CVD etiology.
Prediction of Metabolic Syndrome by Low Serum Testosterone Levels in Men
- MedicineDiabetes
- 2009
Results suggest low testosterone as a strong predictor for incident MetS in young men aged 20–39 years, and Assessment of testosterone in young and middle-age men may allow early interventions in the general population.
Prognostic Value of Dehydroepiandrosterone-Sulfate and Other Parameters of Adrenal Function in Acute Ischemic Stroke
- Medicine, BiologyPloS one
- 2013
DHEA and the cortisol/DHEAS ratio predicts functional outcome 1 year after stroke whereas cortisol levels predict functional outcome and mortality.
Are dehydroepiandrosterone sulphate and lipids associated with erectile dysfunction?
- MedicineMaturitas
- 2005
Association between Androgenic Hormone Levels and Left Ventricular Ejection Fraction
- MedicineThe journal of Tehran Heart Center
- 2010
A significant association was found between the level of fT and EF < 35%.
New evidence for protective effects of DHEAS on health among men but not women
- Medicine
- 2006
The evidence to date from this study and other investigations based on longitudinal data suggests that DHEAS is protective of some health outcomes for men, but not women, in both Western and non-Western populations and raises questions about what factors give rise to these sex differences.
Comparison of Clinical and Biochemical Markers of Hirsutism in Polycystic Ovary Syndrome – A Study from a Teaching Hospital in Sri Ramachandra Institute, Chennai, India
- Medicine, BiologyJournal of Evolution of Medical and Dental Sciences
- 2021
There is an age-associated decline in DHEAS levels which is similar in both control and poly cystic ovaries women, regardless of the race, and bioavailable testosterone, free androgen index, and free testosterone correlated significantly with follicle count, ovarian volume, and hirsutism scores.
DHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health--National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women's Ischemia Syndrome Evaluation (WISE).
- MedicineThe Journal of clinical endocrinology and metabolism
- 2010
Among postmenopausal women with coronary risk factors undergoing coronary angiography for suspected myocardial ischemia, lower DHEA-S levels were linked with higher CVD mortality and all-cause mortality.
References
SHOWING 1-10 OF 62 REFERENCES
Dehydroepiandrosterone sulfate and the risk of myocardial infarction in US male physicians: a prospective study.
- MedicineAmerican journal of epidemiology
- 1994
Findings do not support the hypothesis that elevated plasma DHEAS is associated with a decreased risk of coronary disease in men, but a small to moderate association cannot be excluded.
Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts Male Aging Study.
- MedicineAmerican journal of epidemiology
- 2001
Results confirm prior evidence that low DHEA and DHEAS can predict ischemic heart disease in men, independently of a comprehensive set of known risk factors including age, obesity, diabetes, hypertension, smoking, serum lipids, alcohol intake, and physical activity.
Dehydroepiandrosterone Sulfate, Incidence of Myocardial Infarction, and Extent of Atherosclerosis in Men
- Medicine, BiologyCirculation
- 1992
Findings do not support a role of DHEAS in the development of nonfatal myocardial infarction or the progression of atherosclerosis, and suggest continued skepticism that D HEAS has an important role in coronary disease etiology or prevention.
Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease.
- Medicine, Biology
- 1996
There is still a lack of understanding of the basic biological effects of DHEA and DHEAS and further data both in men and in women from prospective studies and randomized trials are urgently needed.
Dehydroepiandrosterone sulfate, diseases and mortality in a general aged population
- MedicineAging
- 1999
Low plasma DHEAS appears to be a secondary phenomenon rather than a specific risk indicator of common diseases in old age, and gender differences in DHEas persisted up to the age of 75 years.
The Epidemiology of DHEAS and Cardiovascular Disease
- MedicineAnnals of the New York Academy of Sciences
- 1995
An update on the epidemiology of DHEAS and CVD based on a 19-year follow-up of 1,029 men and 942 women aged 30-88 years from the Rancho Bernardo cohort, which reported that high levels of plasma dehydroepiandrosterone sulfate reduced the risk of fatal cardiovascular disease (CVD) in 242 men and increased the risk in 289 women in 1986.
The relationship of natural androgens to coronary heart disease in males: a review.
- Medicine, BiologyAtherosclerosis
- 1996
Evidence for an association between dehydroepiandrosterone sulfate and nonfatal, premature myocardial infarction in males.
- Medicine, BiologyCirculation
- 1994
Serious data indicate that serum dehydroepiandrosterone sulfate levels are inversely related to premature myocardial infarction in males and that this association is independent of the effects of several known risk factors for premature my Cardiac Infarction.
Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients undergoing diagnostic coronary angiography.
- Medicine, BiologyJournal of the American College of Cardiology
- 1990
Dehydroepiandrosterone sulfate does not predict cardiovascular death in postmenopausal women. The Rancho Bernardo Study.
- MedicineCirculation
- 1995
Although higher DHEAS levels were associated with several major CVD risk factors, they were unrelated to the risk of fatal CVD in women.